MCTA
Charming Medical·NASDAQ
--
--(--)
--
--(--)
7.26 / 10
Outperform
Capital flow assessment shows a 7.26/10 score, indicating robust liquidity with Small trends exhibiting a positive inflow ratio of 0.5072. However, block, Medium, Large, and Extra-large patterns show negative trends, creating a mixed but still favorable liquidity outlook. The sentiment score of 7.26 aligns with the positive technical and fundamental aspects, reinforcing the overall positive stance. No analyst coverage data is available, so the analysis focuses on fund flow and sentiment.
Fund Flow Rating
What is the analyst consensus for MCTA?
- MCTA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.26/10 (Outperform).
